The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dabrafenib and trametinib in patients with tumors with BRAF V600E/K mutations: Results from the molecular analysis for therapy choice (MATCH) Arm H.
 
April K.S. Salama
Consulting or Advisory Role - Array BioPharma; BioCryst; Bristol-Myers Squibb; Merck
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Abbvie (I); Bristol-Myers Squibb (Inst); Celldex (Inst); Dynavax Technologies (Inst); Genentech (Inst); Immunocore (Inst); Merck (Inst); Reata Pharmaceuticals (Inst)
 
Shuli Li
No Relationships to Disclose
 
Erin Renee Macrae
No Relationships to Disclose
 
Jong-In Park
No Relationships to Disclose
 
Edith P. Mitchell
Honoraria - Sanofi
Consulting or Advisory Role - Genentech; Merck; Novartis
Research Funding - Genentech (Inst); sanofi (Inst)
 
James A. Zwiebel
Consulting or Advisory Role - Boston Pharmaceuticals; Scandinavian Development Services
 
Helen X. Chen
No Relationships to Disclose
 
Robert James Gray
Research Funding - Abbvie; Agios; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Genomic Health; Genzyme; GlaxoSmithKline; Janssen-Ortho; Merck Sharp & Dohme; Novartis; Onyx; Pfizer; Sanofi; Sequenta; Syndax; Takeda
 
Lisa McShane
No Relationships to Disclose
 
Lawrence Rubinstein
No Relationships to Disclose
 
David Patton
No Relationships to Disclose
 
Paul M. Williams
Research Funding - Illumina (Inst)
Patents, Royalties, Other Intellectual Property - I was a co-inventor of the DLBCL cell of origin patent recently filed by the NIH
 
Stanley R. Hamilton
Consulting or Advisory Role - Bristol-Myers Squibb; Guardant Health; HalioDx; Loxo; Merck; Thermo Fisher Scientific
 
Deborah Kay Armstrong
Consulting or Advisory Role - CUE Biopharma
Research Funding - Advaxis (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Pfizer (Inst); Syndax (Inst); Tesaro (Inst)
 
Barbara A. Conley
No Relationships to Disclose
 
Carlos L. Arteaga
Leadership - American Association for Cancer Research
Stock and Other Ownership Interests - Provista Diagnostics
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; KIYATEC; Lilly; Monogram Biosciences; Novartis; Roche; Seragon; Susan G. Komen for the Cure
Research Funding - AstraZeneca; Novartis; Puma Biotechnology; U3Pharma
 
Lyndsay Harris
Patents, Royalties, Other Intellectual Property - Philips Healthcare
 
Peter J. O'Dwyer
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Genentech
Research Funding - Amgen; Bayer; BBI Healthcare; Bristol-Myers Squibb; Celgene; Five Prime Therapeutics; Forty Seven; Genentech; GlaxoSmithKline; Merck; Mirati Therapeutics; Novartis; Pfizer; Pharmacyclics
 
Alice P. Chen
No Relationships to Disclose
 
Keith Flaherty
Stock and Other Ownership Interests - Apricity Health; Checkmate Pharmaceuticals; Clovis Oncology; FOGPharma; Fount Therapeutics; Loxo; Oncoceutics; PIC Therapeutics; Shattuck Labs; Strata Oncology; Tvardi Therapeutics; Vivid Biosciences; X4 Pharma
Consulting or Advisory Role - Adaptimmune; Aeglea Biotherapeutics; Amgen; Array BioPharma; Asana Biosciences; Boston Biomedical; Bristol-Myers Squibb; Cell Medica; Debiopharm Group; FOGPharma; Genentech; Incyte; Lilly; Loxo; Merck; Neon Therapeutics; Novartis; Oncoceutics; Pierre Fabre; Roche; Sanofi; Shattuck Labs; Takeda; Tolero Pharmaceuticals; Tvardi Therapeutics; Verastem
Research Funding - Novartis; Sanofi
Travel, Accommodations, Expenses - Debiopharm Group; Pierre Fabre